Jaime started Temporis Consulting in 2022 to support companies and research institutes with clinical research operations. She is currently engaged to support projects and programs for both medical device and biotechnology companies as well as clinical research sites. Prior to starting Temporis, she was the General Counsel for Instil Bio, an oncology biotechnology company, that went public in March 2021. Jaime joined Instil Bio in November 2020 to oversee all legal matters including the IPO after spending 13 years at Baylor Scott & White Health. While at Baylor, she served as the chief research executive overseeing business operations and legal matters for Baylor Scott & White Research Institute as the COO and SVP of Research. Her prior life science experience includes clinical research and project management in leading health care institutions such as Massachusetts General, Harvard Medical School and Presbyterian Hospital of Dallas.